IP Library Granted Patent US 9,701,979
Granted Patent B2
US 9,701,979 · App. 14/384,692 · Granted Jul 11, 2017

Nucleotide sequences encoding fasciated EAR3 (FEA3) and methods of use thereof

Inventors: Stephen M Allen (Wilmington, DE); David Peter Jackson (New York, NY); Byoung Il Je (Oyster Bay, NY); Mai Komatsu (Wilmington, DE); Young Koung Lee (Huntington, NY); Hajime Sakai (Newark, DE)
Assignee: E I DU PONT DE NEMOURS AND COMPANY COLD SPRING HARBOR LABORATORY
C12N15/8261A01H5/10C12N15/8229C12N15/8241
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,701,979
App. No.
14/384,692
Granted
Jul 11, 2017
Kind
B2
Abstract

Methods and compositions for modulating shoot apical meristem size are provided. Methods are provided for modulating the expression of fea3 sequence in a host plant or plant cell to modulate agronomic characteristics such as altered size and number of organs, including plant seeds.

Claims (7)

1. A method of making a maize plant in which expression of an endogenous FEA3 gene, which encodes a polypeptide having an amino acid sequence of at least 95% sequence identity, based on the Clustal W method of alignment, when compared to SEQ ID NO:3 or 5, is reduced relative to a control plant, the method comprising the steps of:

a. introducing a mutation into the endogenous FEA3 gene; and

b. detecting the mutation

and wherein the maize plant comprising the mutant FEA3 gene exhibits ears that show a progressive enlargement of the tip, extra kernel rows or an overall irregular arrangement of rows as compared to a wild type maize plant.

2. The method of claim 1 wherein using the steps (a) and (b) are done using a Targeting Induced Local Lesions IN Genomics (TILLING) method and wherein the mutation is effective in reducing the expression of the endogenous FEA3 gene or its activity.

3. The method of claim 1 wherein the mutation is a site-specific mutation.

4. The method of claim 1 , wherein the mutation comprises a transposon inserted into the FEA3 gene sequence.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 29, 2022
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: CORTEVA AGRISCIENCE LLC
Reel/Frame 063141/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2017
From: ALLEN, STEPHEN M; KOMATSU, MAI; SAKAI, HAJIME; JACKSON, DAVID PETER; LEE, YOUNG KOUNG; JE, BYOUNG IL
To: E I DUPONT DE NEMOURS AND COMPANY; COLD SPRINGS HARBOUR LABORATORY
Reel/Frame 041797/0362 →
Continuity (3)
Provisional Application 61610645 · Mar 14, 2012
Provisional Application 61751326 · Jan 11, 2013
Related Publication 20150047071A1 · Feb 12, 2015